| 缩写名/全名 |
EXPERT OPIN INV DRUG
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
||||||||||||||||||||
| ISSN号 | 1354-3784 | ||||||||||||||||||||
| 研究方向 | 医学-药学 | ||||||||||||||||||||
| 影响因子 | 2015:4.408, 2016:4.03, 2017:3.883, 2018:4.031, 2019:5.081, | ||||||||||||||||||||
| 出版国家 | ENGLAND | ||||||||||||||||||||
| 出版周期 | Monthly | ||||||||||||||||||||
| 年文章数 | 77 | ||||||||||||||||||||
| 出版年份 | 1994 | ||||||||||||||||||||
| 是否OA | No | ||||||||||||||||||||
| 审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||
| 录用比例 | 一般 | ||||||||||||||||||||
| 投稿链接 | https://mc.manuscriptcentral.com/eoid | ||||||||||||||||||||
| 投稿官网 | http://www.tandfonline.com/toc/ieid20/current | ||||||||||||||||||||
| h-index | 94 | ||||||||||||||||||||
| CiteScore |
|
||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1354-3784%5BISSN%5D | ||||||||||||||||||||
| 中科院SCI期刊分区 （ 2018年新版本） |
|
||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年新版本） |
|
| 中国学者近期发表的论文 | |
| 1. | The Jakinibs in systemic lupus erythematosus: progress and prospects. Author: Mok CC1. Journal: Expert Opin Investig Drugs. 2019 Jan;28(1):85-92. doi: 10.1080/13543784.2019.1551358. Epub 2018 Nov 26. PubMed DOI |
| 2. | Investigational antiviral therapies for the treatment of influenza. Author: Yang J1, Huang Y1, Liu S1,2. Journal: Expert Opin Investig Drugs. 2019 May;28(5):481-488. doi: 10.1080/13543784.2019.1606210. Epub 2019 Apr 24. PubMed DOI |
| 3. | An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer. Author: Wang Z, Fu S. Journal: Expert Opin Investig Drugs. 2016 Jan;25(1):15-30. doi: 10.1517/13543784.2016.1117071. Epub 2015 Nov 26. PubMed |
| 4. | An overview of new GLP-1 receptor agonists for type 2 diabetes. Author: Tomlinson B, Hu M, Zhang Y, Chan P, Liu ZM. Journal: Expert Opin Investig Drugs. 2016;25(2):145-58. doi: 10.1517/13543784.2016.1123249. Epub 2015 Dec 17. PubMed |
| 5. | Free fatty acid receptor agonists for the treatment of type 2 diabetes: drugs in preclinical to phase II clinical development. Author: Li Z, Qiu Q, Geng X, Yang J, Huang W, Qian H. Journal: Expert Opin Investig Drugs. 2016 Aug;25(8):871-90. doi: 10.1080/13543784.2016.1189530. Epub 2016 May 27. PubMed |
| 6. | Discontinued cardiovascular drugs in 2015. Author: Zhao HP, Dai Y, Xiang BR. Journal: Expert Opin Investig Drugs. 2016 Jul 18. [Epub ahead of print] PubMed |
| 7. | Contraceptives with novel benefits. Author: Su Y, Lian QQ, Ge RS. Journal: Expert Opin Investig Drugs. 2012 Jan;21(1):83-90. doi: 10.1517/13543784.2012.642368. Epub 2011 Dec 8. PubMed |
| 8. | Discontinued drugs in 2011: cardiovascular drugs. Author: Zhao HP, Jiang HM, Xiang BR. Journal: Expert Opin Investig Drugs. 2012 Oct;21(10):1449-62. Epub 2012 Jul 25. PubMed |
| 9. | Active ingredients of traditional Chinese medicine in the treatment of diabetes and diabetic complications. Author: Zhang TT, Jiang JG. Journal: Expert Opin Investig Drugs. 2012 Nov;21(11):1625-42. doi: 10.1517/13543784.2012.713937. Epub 2012 Aug 4. PubMed |
| 10. | Terpenoids: natural products for cancer therapy. Author: Huang M, Lu JJ, Huang MQ, Bao JL, Chen XP, Wang YT. Journal: Expert Opin Investig Drugs. 2012 Dec;21(12):1801-18. doi: 10.1517/13543784.2012.727395. Epub 2012 Oct 23. PubMed |
|
|
